Report Adverse Event or Product Quality Complaint    US Site     Global Site

AZmedical Information Logo
  • Prescribing Information
  • Therapy areas
    • All Therapeutic Areas
    • Cardiovascular, Renal and Metabolism
    • Immunology
    • Infection
    • Oncology
    • Rare Disease (Alexion)
    • Respiratory
  • Disease Education
  • Resources
    • Congress Library
    • Clinical Trials
    • Continuing Education
    • Patient Support
    • Pipeline
    • Oncology Pipeline Tool
  • Connect
    • Connect with an MSL
    • Connect with an MSL
    • Submit an Medical Information Request
    • Give Feedback

Search Medical Information

Login

Request a field medical follow-up

  • Home
  • Congress Library
  • ASBMR 2026

American Society for Bone and Mineral Research (ASBMR 2026) Annual Meeting

October 9–12, 2026

  1. All
  2. HypoPT
  3. HPP
  4. Other

PDF

Bone manifestations in chronic hypoparathyroidism: a retrospective cohort study

PDF

Chronic hypoparathyroidism in the US: prevalence and incidence from 2018 to 2024, with baseline clinical characteristics

PDF

Epidemiology of low bone density and osteoporosis in chronic hypoparathyroidism: baseline prevalence and medication usage from national US claims

PDF

Leveraging structured and unstructured EHR data to improve treatment and clinical context capture in chronic hypoparathyroidism

PDF

Methodological differences limit the feasibility of an indirect treatment comparison between the phase III CALYPSO (eneboparatide) and PaTHway (palopegteriparatide) trials in chronic hypoparathyroidism

PDF

A Real-world US survey study characterizing the holistic disease burden in adults with hypophosphatasia

PDF

Cascade diagnosis of the rare metabolic disease hypophosphatasia (HPP) within families: a case series

PDF

Clinical course and candidate biomarkers in perinatal hypophosphatasia: a multicenter observational case series

PDF

Diagnostic delay and persistent disease burden in hypophosphatasia: results from a cross-sectional, multinational, mixed-methods study

PDF

Genetic characterization and clinical manifestations in adult patients with hypophosphatasia

PDF

Longitudinal remote assessments in adults with hypophosphatasia: a patient- and clinician-informed observational study

PDF

Treatment experience in patients with hypophosphatasia (HPP): results of a US survey

PDF

Understanding disease burden in adults with hypophosphatasia: findings from a UK delphi panel study

PDF

Plasma proteomics differentiates ADO penetrance and highlights differential inflammatory and matrix remodeling pathways

PDF

Bone manifestations in chronic hypoparathyroidism: a retrospective cohort study

PDF

Chronic hypoparathyroidism in the US: prevalence and incidence from 2018 to 2024, with baseline clinical characteristics

PDF

Epidemiology of low bone density and osteoporosis in chronic hypoparathyroidism: baseline prevalence and medication usage from national US claims

PDF

Leveraging structured and unstructured EHR data to improve treatment and clinical context capture in chronic hypoparathyroidism

PDF

Methodological differences limit the feasibility of an indirect treatment comparison between the phase III CALYPSO (eneboparatide) and PaTHway (palopegteriparatide) trials in chronic hypoparathyroidism

PDF

A Real-world US survey study characterizing the holistic disease burden in adults with hypophosphatasia

PDF

Cascade diagnosis of the rare metabolic disease hypophosphatasia (HPP) within families: a case series

PDF

Clinical course and candidate biomarkers in perinatal hypophosphatasia: a multicenter observational case series

PDF

Diagnostic delay and persistent disease burden in hypophosphatasia: results from a cross-sectional, multinational, mixed-methods study

PDF

Genetic characterization and clinical manifestations in adult patients with hypophosphatasia

PDF

Longitudinal remote assessments in adults with hypophosphatasia: a patient- and clinician-informed observational study

PDF

Treatment experience in patients with hypophosphatasia (HPP): results of a US survey

PDF

Understanding disease burden in adults with hypophosphatasia: findings from a UK delphi panel study

PDF

Plasma proteomics differentiates ADO penetrance and highlights differential inflammatory and matrix remodeling pathways

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

Connessiallasalute.it

This site is intended for healthcare professionals practicing in the US.
©2026 AstraZeneca. All rights reserved.

US-107328
Last Updated 5/26

Contact Us

About Us

AstraZeneca-US.com

Other Countries

Grant Opportunities  

Survey Feedback

Your Privacy Choice

Consumer Health Data
Privacy Notice

Privacy Notice | Legal Notice | Cookie Preferences

Welcome to AstraZeneca Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

 

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

 

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?
This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States